US › Healthcare

Alpha Tau Medical Ltd (DRTS)

US · Healthcare · Biotechnology

$13.08+9.73%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-22.9M
Profit YoY
-163.9%
EPS
$-0.26
EPS estimate
$-0.12

EPS came in at -0.26 against a street estimate of -0.12 — a miss of 116.7%.

Key statistics

Market cap
$1.06B
Forward P/E
0.0
P/B
15.33
Book value
$0.77
EPS (TTM)
$-0.67
52-week high
$14.11
52-week low
$2.98
50-day MA
$11.22
200-day MA
$7.52
Beta
1.17

Analyst view

Analysts rate Alpha Tau Medical Ltd a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $14.20.

Shareholding

Insiders
31.23%
Institutions
4.94%

Largest institutional holders

FundStake
HighTower Advisors, LLC0.97%
Aquamarine Financial (Cayman) Ltd0.80%
Apella Capital, LLC0.42%
ARK Investment Management LLC0.32%
UBS Group AG0.32%
Kovitz Investment Group Partners, LLC0.16%
Mariner Wealth Advisors LLC0.16%
Daytona Street Capital LLC0.16%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Alpha Tau Medical Ltd — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.